Uric Acid and Kidney Function
Uric acid and kidney function are tangled together in both directions: the kidneys handle most of your urate disposal, so when they slow down urate rises — and higher urate is, in turn, associated with faster decline in kidney function. The tempting conclusion is that lowering urate must protect the kidneys. Two well-run trials went looking for that benefit and did not find it, which is worth knowing before anyone is promised something the evidence does not support.
The kidneys do most of the work
Roughly two-thirds of the urate your body disposes of each day leaves through the kidneys; the remaining third is cleared into the gut, largely via the ABCG2 transporter. That split explains why renal function is the single biggest determinant of where your serum urate sits.
Filtration is only part of it. Urate is filtered at the glomerulus and then mostly reabsorbed further along the tubule, with a set of transporters deciding how much comes back. Reduced clearance in chronic kidney disease therefore raises urate through more than one route, and the drift is usually gradual — a number that was fine ten years ago quietly becoming a number that is not.
Why kidney disease pushes urate up
- Lower filtration. Less urate leaves per day at any given blood level, so the level settles higher.
- Altered tubular handling. Transporter activity shifts in CKD, tilting the balance toward reabsorption.
- Diuretics. Thiazides and loop diuretics are common in kidney disease and heart failure, and both raise urate — often the real reason behind a new gout diagnosis, as diuretics and gout explains.
- Shared company. Insulin resistance, obesity and hypertension reduce urate excretion independently, and they cluster with kidney disease.
The practical result is that gout is considerably more common in people with reduced kidney function, and often harder to treat, because several of the usual tools become less straightforward.
What the association actually shows
Large observational studies consistently find that people with higher serum urate lose kidney function faster. There are plausible mechanisms behind it — urate crystals depositing in the renal medulla, and effects of soluble urate on the endothelium, inflammation and the renin–angiotensin system.
Association is not the same thing as cause, and here the distinction has been tested directly rather than argued about. High urate could be causing kidney decline, or failing kidneys could simply be producing high urate — a marker of the damage rather than its driver.
What the trials found
Two randomised trials published in 2020 tried to settle it.
CKD-FIX gave allopurinol to people with stage 3 or 4 chronic kidney disease who were at risk of progression. PERL gave allopurinol to people with type 1 diabetes and early-to-moderate diabetic kidney disease. Both lowered serum urate as expected. Neither slowed the decline in kidney function compared with placebo.
That is a genuinely disappointing result and it should be reported as one. It does not mean urate is irrelevant to the kidney, and it does not mean nobody benefits — the trials studied particular populations over particular timeframes, and mostly in people without gout. What it does mean is that lowering urate purely to protect the kidneys is not an established treatment, and anyone claiming otherwise is ahead of the evidence.
How to hold both ideas: if you have gout and reduced kidney function, urate-lowering therapy is about your joints, your tophi and the crystals already deposited — all of which are strong reasons on their own. Treat any kidney benefit as unproven, and judge the treatment on what it is actually for.
What it changes about treatment
Reduced kidney function does not rule out treating gout. It changes how it is done, and every one of these decisions belongs to your prescriber rather than to a website.
| Drug | How reduced kidney function affects its use |
|---|---|
| Allopurinol | Still first line. Started at a lower dose in CKD and titrated slowly upward against results; the old habit of capping the dose by creatinine has largely been abandoned in favour of careful escalation to target. |
| Febuxostat | Cleared mainly by the liver, so less dose adjustment is needed in kidney impairment. Cardiovascular safety is weighed separately — see allopurinol vs febuxostat. |
| Probenecid | Works by increasing urinary urate excretion, so it becomes progressively less effective as filtration falls and is generally avoided at lower eGFR. |
| Colchicine | Doses are reduced in kidney impairment, and interactions matter more. Colchicine dose and timing covers the detail. |
| NSAIDs | Often unsuitable, since they reduce renal blood flow. This is a frequent reason flares are managed differently in CKD. |
| Corticosteroids | Frequently preferred for acute flares when NSAIDs are off the table, with their own trade-offs in diabetes. |
The broader menu and how the options compare sits in gout medications compared. The one rule that does not bend: nothing here is a reason to adjust a dose yourself. If your kidney numbers have changed, that is a prompt for a review, not for improvising.
What is worth doing anyway
Much of what helps urate helps kidneys through separate routes, so the overlap is useful even without a proven urate-to-kidney effect. Blood pressure control, better glycaemic control, weight loss and not being repeatedly dehydrated all matter in their own right. So does knowing which of your prescriptions raise urate — losartan and SGLT2 inhibitors happen to lower it, which occasionally makes one blood-pressure or diabetes drug a tidier choice than another for someone who also has gout. That, again, is a conversation with your prescriber, not a swap to make on your own.
Frequently Asked Questions
Does high uric acid damage the kidneys?
It is consistently associated with faster kidney function decline, and there are plausible mechanisms. But the trials that lowered urate specifically to slow that decline did not show a benefit, so causation remains unproven. High urate is best treated as a signal worth understanding rather than a proven cause.
Is allopurinol safe if I have chronic kidney disease?
It is widely used in CKD, typically starting at a lower dose and increasing gradually while urate and kidney function are monitored. The specifics depend on your eGFR, your other medicines and your history, which is why the starting dose is set individually.
Why did my uric acid rise when nothing about my diet changed?
Falling kidney function is one of the commonest explanations, along with a newly started diuretic. Diet moves serum urate by roughly 0.3 to 1.3 mg/dL (about 18 to 78 µmol/L), so a large unexplained rise usually points somewhere other than the kitchen.
Should I take urate-lowering therapy just to protect my kidneys?
On current evidence, that alone is not a standard indication. If you also have gout, tophi or recurrent flares, there are strong reasons to treat regardless — and the target for that is set in the uric acid target that actually matters.
What to read next
- What Happens If Gout Goes Untreated — the long-term picture beyond the joint.
- Allopurinol for Gout: A Practical Guide — starting, titrating and monitoring.
- High Uric Acid With No Symptoms — when a raised number is watched rather than treated.
- Diuretics and Gout: A Hidden Cause — the prescription behind many new diagnoses.
